Ocugen, Inc. — Director's Dealing 2020

Aug 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2020-08-14

Reporting Person: Tammara Vijay (Senior Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-14	Options (Right to Buy)	$0.565	A	50000	Acquired	2030-08-14	Common Stock (50000)	Direct

Footnotes

F1: The options will vest in equal monthly installments over three years commencing on August 14, 2020, subject to continued employment with the Company on the applicable vesting dates.